---

February 07, 2024

Predictmedix AI Rolls Out Advanced AI-Powered Safe Entry Stations at Trinity Hospital

First deployment in Northeast India to serve as showcase for 8 Northeastern states Revenue generating with potential for significant expansion   Toronto, Ontario – January XX, 2024 – Predictmedix AI Inc. (CSE: PMED) (OTCQB: PMEDF)…

Read full release →

January 11, 2024

Predictmedix AI Unveils Technological Advances Including Publishing of Peer-Reviewed Paper

TORONTO, ON / ACCESSWIRE / January 11, 2024 / Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) (the “Company” or “Predictmedix”), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), proudly announces significant technological advances…

Read full release →

December 18, 2023

Predictmedix AI Elevates Safe Entry Stations with Cutting-Edge Facial Recognition Technology

Toronto, Ontario – December 18th, 2023 – Predictmedix AI Inc. (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), today announced…

Read full release →

December 05, 2023

Predictmedix AI Achieves Significant Milestones in Mental Health Detection and Analysis

Toronto, Ontario – December 5th, 2023 – Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI) is proud…

Read full release →

November 14, 2023

Predictmedix AI Announces Successful Clinical Validation at the University of Raharja, Indonesia, Demonstrating 95% Accuracy in Vital Sign Detection

Toronto, Ontario – November 14, 2023 – Predictmedix AI Inc.  (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI) is proud…

Read full release →